+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immune Pharmaceuticals - logo

Immune Pharmaceuticals is a clinical stage biopharmaceutical company that develops novel targeted therapeutics in the immuno-inflammation and immuno-oncology areas. The company's lead product candidate is Bertilimumab, a human monoclonal antibody, which is in Phase II clinical trial for the treatment of ulcerative colitis, bullous pemphigoid, and Crohn's disease. Immune Pharmaceuticals, Inc. was founded in 2010 and is headquartered in New York, New York.

Bullous Pemphigoid Global Clinical Trials Review, H2, 2018 - Product Thumbnail Image

Bullous Pemphigoid Global Clinical Trials Review, H2, 2018

  • Clinical Trials
  • December 2018
  • 59 pages
From
Low Back Pain - Pipeline Review, H2 2020 - Product Thumbnail Image

Low Back Pain - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 138 pages
From
Diabetic Neuropathy - Pipeline Review, H2 2020 - Product Thumbnail Image

Diabetic Neuropathy - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 143 pages
From
Pemphigus Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Pemphigus Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • April 2018
  • 67 pages
From
From
From
Neuropathic Pain - Pipeline Review, H2 2019 - Product Thumbnail Image

Neuropathic Pain - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 838 pages
From
From
From
From
Diabetic Peripheral Neuropathy - Pipeline Review, H2 2020 - Product Thumbnail Image

Diabetic Peripheral Neuropathy - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 97 pages
From
Chronic Neuropathic Pain (CNP) - Pipeline Insight, 2019 - Product Thumbnail Image

Chronic Neuropathic Pain (CNP) - Pipeline Insight, 2019

  • Clinical Trials
  • September 2019
  • 60 pages
From
From
From
Antibody Contract Manufacturing Market, 2020 - 2030 - Product Thumbnail Image

Antibody Contract Manufacturing Market, 2020 - 2030

  • Report
  • January 2020
  • 305 Pages
From
From
Loading Indicator
adroll